%0 Case Reports
%T Tumor reduction after SARS‑CoV‑2 infection in a patient with lung cancer: A case report.
%A Zhang X
%A Chen J
%A Sun J
%A Gao S
%A Zhao F
%A Qian N
%J Oncol Lett
%V 27
%N 4
%D 2024 Apr
%M 38455664
%F 3.111
%R 10.3892/ol.2024.14302
%X Lung cancer is one of the most common malignancies worldwide. Since the global outbreak of the coronavirus disease 2019 (COVID-19) pandemic in 2020, the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on lung cancer has been extensively studied. Despite reports about SARS-CoV-2 infection inducing a significant increase in the number of medical visits for patients with cancer, the virus has also been reported to produce some unknown benefits. The present study reports the case of a patient with lung cancer whose tumor lesion was reduced in size after SARS-CoV-2 infection even though the therapeutic regimen remained unchanged. Although the mechanism involved is not yet understood, this case supports the novel idea of applying SARS-CoV-2 in oncolytic virotherapy.